Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat. (Q51396913)

4 April 2018

title

Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat. (English)

1 reference

4 April 2018

1 reference

4

1 reference

4 April 2018

Susanna Genedani

7

1 reference

4 April 2018

author name string

Vergoni AV

1

1 reference

4 April 2018

Ottani A

2

1 reference

4 April 2018

Botticelli AR

3

1 reference

4 April 2018

Guano L

5

1 reference

4 April 2018

Loche A

6

1 reference

4 April 2018

Gessa GL

8

1 reference

4 April 2018

Bertolini A

9

1 reference

4 April 2018

language of work or name

English

0 references

publication date

1 May 2000

1 reference

4 April 2018

European Journal of Pharmacology

published in

1 reference

4 April 2018

volume

397

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

75-84

1 reference

4 April 2018

Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

gamma-Hydroxybutyrate: cerebral metabolic, vascular, and protective effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Influence of various agents on the development of brain edema in the rat following microembolism. Protective effect of gamma-butyrolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The effects of 4-hydroxybutyric acid on the biosynthesis of amino acids in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Regional distribution of high-affinity gamma-[3H]hydroxybutyrate binding sites as determined by quantitative autoradiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Pyretic action of low doses of gamma-hydroxybutyrate in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

7 January 2021

Sodium 4-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Effect of low dose gamma-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Effects of gamma-hydroxybutrate and gamma-butyrolactone on cerebral energy metabolism during exposure and recovery from hypoxemia-oligemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Subcellular distribution of gamma-hydroxybutyrate binding sites in rat brain principal localization in the synaptosomal fraction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The neuropharmacological and neurochemical basis of place learning in the Morris water maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Developments of a water-maze procedure for studying spatial learning in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Pharmacological aspects of human and canine narcolepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

A new model of bilateral hemispheric ischemia in the unanesthetized rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Barbiturate protection in acute focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Cerebral protection with barbiturates: relation to anesthetic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Significance of gamma-hydroxybutyric acid in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Gamma-hydroxybutyrate, a possible neurotransmitter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

7 January 2021

Gammahydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Effects of gamma-butyrolactone on local cerebral glucose utilization in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

γ-Hydroxybutyrate hyperpolarizes hippocampal neurones by activating GABAB receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

Experimental Brain Ischemia: Protection From Irreversible Damage With a Rapid-Acting Barbiturate (Methohexital)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

The protective effect of gamma-hydroxybutyrate in regional intestinal ischemia in the hamster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900246-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00246-6

1 reference

4 April 2018

1 reference

4 April 2018